---
schema_version: "secwatch.filing_event.v1"
accession: "0000310764-25-000103"
form_type: "8-K"
ticker: "SYK"
cik: "0000310764"
company_name: "STRYKER CORP"
filed_at: "2025-07-31T23:59:59+00:00"
generated_at: "2026-05-17T22:32:05.396937+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Stryker Q2 2025: net sales $6.0B +11.1%, adj EPS $3.13 +11.4%, raises FY guidance

## Summary
- Net sales $6.0B +11.1% reported (+10.2% organic); MedSurg/Neuro +17.3%, Orthopaedics +2.0% (ex-spinal +10.7%).
- Reported EPS $2.29 +7.0%; adjusted EPS $3.13 +11.4%. Adj. operating margin 25.7% +110 bps.
- FY 2025 guidance raised: organic sales growth 9.5-10.0%, adj EPS $13.40-$13.60.
- Tariff impact estimated at ~$175M net, reflecting US-China reduction and proposed US-EU framework.

## SEC filing metadata
- accession: 0000310764-25-000103
- form_type: 8-K
- ticker: SYK
- cik: 0000310764
- company_name: STRYKER CORP
- filed_at: 2025-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310764/000031076425000103/0000310764-25-000103-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310764/000031076425000103/syk-20250731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000310764-25-000103
- JSON: https://secwatch.observer/filing/0000310764-25-000103.json
- Plain text: https://secwatch.observer/filing/0000310764-25-000103.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.